Growth hormone and skin biology are closely connected through the activity of fibroblasts, keratinocytes and other cells responsible for maintaining the skin’s structure. Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) influence several processes involved in dermal maintenance, extracellular matrix production and cellular responses to injury.
Human endocrine disorders provide evidence of these relationships. People with chronic GH excess can develop thickened skin, increased sweating and changes in sebaceous gland activity, while some patients with GH deficiency exhibit thinner, drier skin.
Laboratory studies have also examined whether GH-related signalling influences wound repair.
However, demonstrating changes in skin-cell activity is not equivalent to establishing that increasing GH improves skin appearance, accelerates wound healing or reverses skin ageing in humans.
How Does Growth Hormone Affect the Skin?
Human skin consists of several interacting layers and cell populations.
The epidermis provides an external barrier and contains keratinocytes responsible for much of its structure.
The dermis contains fibroblasts, collagen fibres, blood vessels, nerves and other supporting components.
Growth hormone receptors have been identified in several skin-cell populations.
GH can influence these cells directly through receptor-mediated signalling or indirectly through IGF-1.
The GH–IGF-1 axis therefore contributes to interactions between epidermal and dermal tissues.
Its effects depend on cell type, local growth factor availability and the physiological condition being studied.
6 Research Findings About Growth Hormone and Skin Biology
1. Skin Cells Respond to GH and IGF-1 Signalling
GH receptors are expressed across several components of human skin, including dermal and epidermal structures.
IGF-1 signalling is also important in skin physiology, particularly in processes involving epidermal keratinocytes.
GH receptor activation can engage intracellular pathways such as JAK2–STAT5, while IGF-1 receptors activate pathways associated with cellular growth and survival.
These signalling systems are related but not identical.
A review published in Endocrine Reviews examined the importance of GH and IGF signalling in maintaining epidermal and dermal homeostasis.
The authors highlighted interactions between the two systems and their influence on communication between skin layers.
This research helps explain why skin should be considered an endocrine-responsive organ rather than a passive protective covering.
However, receptor expression does not establish that increasing hormone exposure improves skin function.
2. Growth Hormone Influences Dermal Fibroblast Activity
Fibroblasts are specialised cells responsible for producing many components of the dermal extracellular matrix.
These include collagen and other structural molecules that help maintain tissue organisation.
Experimental research indicates that GH can influence fibroblast proliferation and local IGF-1 production.
A study published in the Journal of Plastic, Reconstructive & Aesthetic Surgery examined human fibroblasts exposed to GH under laboratory conditions.
The researchers observed greater fibroblast proliferation in GH-exposed cultures compared with controls.
They also reported increased IGF-1 expression.
These findings provide evidence that GH can influence dermal cellular activity.
However, cell proliferation in culture does not establish improved skin quality or tissue repair in a living human.
The extracellular matrix must also be organised appropriately to support normal tissue function.
3. GH and IGF-1 Participate in Collagen Regulation
Collagen is a major structural component of the dermis.
Type I and type III collagen contribute to the extracellular matrix, while other collagen types perform specialised functions in the skin.
GH and IGF-1 participate in pathways associated with collagen production and connective tissue growth.
Research involving endocrine disorders has demonstrated that prolonged GH excess can produce skin thickening and connective tissue expansion.
However, increased skin thickness should not automatically be interpreted as improved skin health.
In acromegaly, changes in dermal structure may involve excessive extracellular matrix accumulation, glycosaminoglycan deposition and altered tissue hydration.
These changes can produce coarse skin texture and soft tissue enlargement.
This demonstrates an important principle: increased extracellular matrix production can represent physiological maintenance or pathological remodelling depending on the circumstances.
Our growth hormone and IGF-1 research guide explains how direct GH activity differs from downstream IGF-1 signalling.
4. GH-Related Signalling Can Influence Keratinocyte Migration
Keratinocytes contribute to the skin barrier and play an important role in wound closure.
Following injury, keratinocytes migrate across the wound surface to help restore epidermal continuity.
This process is known as re-epithelialisation.
The human cell-culture study described earlier also examined keratinocyte migration under GH-related experimental conditions.
Researchers reported increased migration in GH-exposed cultures compared with controls.
The findings were associated with increased local IGF-1 formation.
These observations suggest that GH-related signalling can influence cellular processes involved in wound repair.
However, a migration assay measures the movement of cells under controlled laboratory conditions.
It does not establish faster healing, reduced scarring or improved wound outcomes in patients.
Human wound healing involves additional processes, including inflammation, vascular responses, extracellular matrix remodelling and infection control.
5. GH Deficiency and Excess Produce Different Skin Changes
Clinical observations provide evidence that GH activity influences skin structure and function.
In GH deficiency, reported findings include thin or dry skin, reduced sweating and altered epidermal morphology.
In acromegaly, chronic GH and IGF-1 excess can be associated with thickened skin, increased sebum production, enlarged pores, skin tags and excessive sweating.
A clinical study comparing patients with GH deficiency, acromegaly and healthy controls examined skin biopsies and sweating measurements.
The researchers found reduced epidermal thickness and sweat secretion in participants with GH deficiency.
Importantly, some abnormalities persisted despite GH treatment.
This indicates that the relationship between hormone concentrations and skin morphology is not always rapidly reversible.
It also illustrates why studies involving established endocrine disorders cannot be generalised to healthy individuals seeking cosmetic changes.
6. Skin Ageing and Wound Repair Require More Than Hormone Measurements
Skin ageing involves changes in collagen organisation, epidermal turnover, pigmentation, vascular function and the extracellular matrix.
Ultraviolet exposure, smoking, inflammation and other environmental factors also contribute.
Although GH secretion generally declines with age, this does not establish that declining GH is the principal cause of skin ageing.
Nor does evidence of GH-related fibroblast activity prove that GH exposure reverses wrinkles or improves skin elasticity.
Similarly, wound healing depends on coordinated inflammatory, proliferative and remodelling processes.
A 2024 review of hormonal interventions in skin wounds discussed the involvement of several hormones and growth factors in tissue repair.
The available evidence supports further investigation of endocrine signalling in wound biology.
It does not establish GH-related research compounds as proven treatments for wounds or cosmetic skin ageing.
Fibroblasts vs Keratinocytes: Different Roles in Skin Research
Fibroblasts and keratinocytes are frequently discussed together, but they perform different functions.
| Characteristic | Fibroblasts | Keratinocytes |
|---|---|---|
| Primary location | Dermis | Epidermis |
| Main structural role | Produce extracellular matrix components | Form and maintain the epidermal barrier |
| Relevant GH–IGF-1 research | Proliferation and collagen-related activity | Migration, proliferation and differentiation |
| Role in wound repair | Matrix deposition and tissue remodelling | Re-epithelialisation |
| Common laboratory methods | Proliferation assays, collagen analysis | Migration assays, barrier-related measurements |
| Key limitation | Increased proliferation does not prove stronger tissue | Increased migration does not prove complete wound healing |
Both cell populations interact during tissue repair.
For example, fibroblast-derived growth factors can influence keratinocyte behaviour, while epidermal signals can affect dermal activity.
This communication is essential to understanding skin biology.
What Does Acromegaly Reveal About GH and Skin Structure?
Acromegaly provides a human model of prolonged GH and IGF-1 excess.
Its dermatological manifestations include thickened skin, increased sweating, skin tags and changes in sebaceous activity.
These effects can involve dermal fibroblasts, glycosaminoglycan accumulation and altered glandular function.
The condition demonstrates that GH-related signalling can produce visible structural changes in human skin.
However, the changes are not necessarily desirable.
Some manifestations improve when GH and IGF-1 excess is controlled, although complete reversal is not guaranteed.
This is why findings from acromegaly should not be used to support claims that increasing GH produces healthier or younger-looking skin.
What Should Researchers Measure in GH–Skin Studies?
Studies examining growth hormone and skin biology require measurements matched to the process being investigated.
Fibroblast proliferation: Assesses changes in cell growth under controlled experimental conditions.
Collagen synthesis: Evaluates production of extracellular matrix proteins.
Keratinocyte migration: Measures cellular movement relevant to re-epithelialisation.
Skin thickness: Provides structural information but does not independently establish tissue quality.
Barrier function: Can be assessed using measurements such as transepidermal water loss.
Wound closure: Requires direct evaluation of repair outcomes in appropriate experimental or clinical models.
GH and IGF-1 concentrations: Characterise endocrine activity but cannot replace tissue-specific measurements.
A study that demonstrates increased collagen production should not automatically claim improved wound healing.
Likewise, a reduction in wound area does not necessarily establish that the repaired tissue has regained normal strength or barrier function.
Understanding the Wider GH–IGF-1 Research Context
The skin is one of several organs affected by GH–IGF-1 signalling.
The same endocrine pathways also participate in muscle protein metabolism, connective tissue regulation and age-related physiological changes.
Our growth hormone and ageing article provides further context for changes in GH secretion across adulthood.
For UK laboratories exploring endocrine signalling, peptide biochemistry and cellular research, Peptide Lab Direct UK is our featured UK research peptide supplier, offering a specialist platform for research compounds relevant to laboratory investigations.
The strongest conclusion from current research is that GH and IGF-1 participate in skin-cell regulation, but their effects depend on the tissue, experimental conditions and clinical context.
Frequently Asked Questions
Does growth hormone affect skin cells?
Yes. GH and IGF-1 participate in signalling pathways involving fibroblasts, keratinocytes and other skin-cell populations.
Does GH increase collagen production?
Research indicates that GH–IGF-1 signalling can influence collagen synthesis and connective tissue growth, although increased collagen does not always indicate healthier tissue.
What is the role of IGF-1 in skin biology?
IGF-1 participates in cellular growth, epidermal regulation and interactions between skin-cell populations.
Can growth hormone accelerate wound healing?
Laboratory studies have reported changes in fibroblast proliferation and keratinocyte migration, but these findings do not establish consistent clinical wound-healing benefits.
Why does acromegaly cause thickened skin?
Chronic GH and IGF-1 excess can increase connective tissue growth and glycosaminoglycan accumulation, contributing to skin thickening.
Is growth hormone proven to reverse skin ageing?
No. Current evidence does not establish GH as a proven intervention for reversing normal skin ageing in healthy adults.
Scientific References
- Edmondson SR, Thumiger SP, Werther GA, Wraight CJ. Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocrine Reviews. 2003.
https://pubmed.ncbi.nlm.nih.gov/14671001/ - The effect of growth hormone on fibroblast proliferation and keratinocyte migration. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2010.
https://pubmed.ncbi.nlm.nih.gov/20022575/ - Skin morphological changes in growth hormone deficiency and acromegaly. European Journal of Endocrinology. 2001.
https://pubmed.ncbi.nlm.nih.gov/11454509/ - Skin manifestations of growth hormone-induced diseases. Scientific review. 2016.
https://pubmed.ncbi.nlm.nih.gov/27571787/ - Endocrine Controls of Skin Aging. Endocrine Reviews. 2025.
https://academic.oup.com/edrv/article/46/3/349/8029650 - Hormonal interventions in skin wounds – a mini review. 2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11566089/
Research-only notice: This article is intended for scientific education and laboratory research. It does not provide medical advice, cosmetic treatment recommendations or instructions for administering research compounds.